Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001

K-Number: K844110 · 1984-11-19

ApplicantPelco, Inc.
Decision Date1984-11-19
Product CodePYE
Advisory CommitteeSU
DecisionSubstantially Equivalent

Device Summary

XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001 is the device name listed in this FDA 510(k) record. The listed applicant is Pelco, Inc.. It received FDA 510(k) clearance on 1984-11-19 under 510(k) number K844110. The device is classified under product code PYE. It was reviewed by the SU advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001?

XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001 is a medical device that received FDA 510(k) clearance on 1984-11-19. The listed applicant is Pelco, Inc.. The 510(k) number is K844110.

When did XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001 receive FDA 510(k) clearance?

XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001 received FDA 510(k) clearance on 1984-11-19, under 510(k) number K844110.

Who is the listed applicant for XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001?

The FDA 510(k) record lists Pelco, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001?

The FDA product code for XTRACETEZE SURGICAL SKIN STAPLE REMOVER 2001 is PYE.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑